Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.
about
Molecular studies of exercise, skeletal muscle, and ageingInhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and BeyondThe role of the ribosome in the regulation of longevity and lifespan extensionNaturally occurring p16(Ink4a)-positive cells shorten healthy lifespanAlcohol impairs skeletal muscle protein synthesis and mTOR signaling in a time-dependent manner following electrically stimulated muscle contractionReducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.Reduced in vivo hepatic proteome replacement rates but not cell proliferation rates predict maximum lifespan extension in mice.Reduced insulin/insulin-like growth factor signaling decreases translation in Drosophila and mice.The role of mTOR signalling in the regulation of skeletal muscle mass in a rodent model of resistance exercise.Aging is not programmed: genetic pseudo-program is a shadow of developmental growth.Key proteins and pathways that regulate lifespan.Intact neuronal function in Rheb1 mutant mice: implications for TORC1-based treatments.Transcriptional programming of lipid and amino acid metabolism by the skeletal muscle circadian clock
P2860
Q26745904-EA466B44-57CB-4706-9C9B-10D229513E2CQ26751462-3AFFF108-8734-4328-8031-36A39DAB3A3FQ26770848-4302CE3F-FA57-4F0B-8743-57B47B03CB56Q28005547-6D69DADC-8883-4A12-A6B0-11308444B3DCQ34519008-A9BD16F2-12A5-4E57-A1BE-C87BF67281E1Q36157810-34251450-9C96-45E2-90E5-0083E658D45AQ36475214-14D23E58-D7A2-460E-B12D-7C5AC6EF409AQ37121889-7C3711BE-4CC9-4BEF-AACE-C5F8B375BAEFQ37160004-EB299EEE-A474-4F64-97AA-5F16454EFA63Q37525814-FD2CD67F-73F0-4B6F-8FDB-4364497758E0Q38926261-0EF5CFFF-36E0-4BEC-9E55-0B4D7C08E8FDQ48286797-6CFD55A5-32A7-4BBE-98C4-B3BED4DC6AE6Q58789750-AF2B460B-F0CC-4082-B07E-96CCA4694039
P2860
Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.
@en
Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.
@nl
type
label
Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.
@en
Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.
@nl
prefLabel
Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.
@en
Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.
@nl
P2093
P2860
P356
P1433
P1476
Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo
@en
P2093
Aya Yanagida
Emmeline C Academia
Katherine H Schreiber
Michael G Garelick
Vivian L Mackay
Warren C Ladiges
P2860
P304
P356
10.4161/CC.25512
P577
2013-07-01T00:00:00Z